Stemtech Corporation (STEK)

Market Cap	3.19M
Revenue (ttm)	5.10M
Net Income (ttm)	-5.24M
Shares Out	136.47M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	53,050
Average Volume	459,556
Open	0.0269
Previous Close	0.0245
Day's Range	0.0218 - 0.0269
52-Week Range	0.0101 - 0.0650
Beta	2.23
RSI	36.67
Earnings Date	Apr 1, 2025

About Stemtech

Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. Its products enhance and support the work of the body’s stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. The company offers its dietary supplements products under the RCM System, stemrelease3, Stemflo MigraStem, OraStem, and D-Fuz...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: STEK

Financial Performance

In 2023, Stemtech's revenue was $4.92 million, an increase of 7.94% compared to the previous year's $4.56 million. Losses were -$5.43 million, -36.45% less than in 2022.